metricas
Medicina Clínica (English Edition) Immune-mediated diabetes associated with pembrolizumab
Journal Information
Vol. 161. Issue 1.
Pages 1-48 (July 2023)
Cite
Cite
Share
Download PDF
More article options
Vol. 161. Issue 1.
Pages 1-48 (July 2023)
Letter to the Editor

Immune-mediated diabetes associated with pembrolizumab

Diabetes inmunomediada asociada a pembrolizumab
Visits
721
Javier Bodoque Cubas
Corresponding author
xavierbcubas.end@gmail.com

Corresponding author.
, Juan José Salazar González, Marcel.la Miret Llauradó
Hospital de Tortosa Verge de la Cinta, Tortosa, Tarragona, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
asdasdasd
Article options
Tools